Baggen, J., Jacquemyn, M., Persoons, L., Vanstreels, E., Pye, V. E., Wrobel, A. G., . . . Daelemans, D. (2023). TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. Cell, 186(16), 3427. https://doi.org/10.1016/j.cell.2023.06.005
Chicago Style (17th ed.) CitationBaggen, Jim, et al. "TMEM106B Is a Receptor Mediating ACE2-independent SARS-CoV-2 Cell Entry." Cell 186, no. 16 (2023): 3427. https://doi.org/10.1016/j.cell.2023.06.005.
MLA (9th ed.) CitationBaggen, Jim, et al. "TMEM106B Is a Receptor Mediating ACE2-independent SARS-CoV-2 Cell Entry." Cell, vol. 186, no. 16, 2023, p. 3427, https://doi.org/10.1016/j.cell.2023.06.005.
Warning: These citations may not always be 100% accurate.